| Year |
Citation |
Score |
| 2013 |
Houri N, Huang KC, Nalbantoglu J. The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP). Plos One. 8: e73296. PMID 24015300 DOI: 10.1371/Journal.Pone.0073296 |
0.325 |
|
| 2012 |
Robert MA, Lin Y, Bendjelloul M, Zeng Y, Dessolin S, Broussau S, Larochelle N, Nalbantoglu J, Massie B, Gilbert R. Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors. The Journal of Gene Medicine. 14: 746-60. PMID 23071006 DOI: 10.1002/Jgm.2675 |
0.408 |
|
| 2011 |
Bergeron S, Dubois MJ, Bellmann K, Schwab M, Larochelle N, Nalbantoglu J, Marette A. Inhibition of the protein tyrosine phosphatase SHP-1 increases glucose uptake in skeletal muscle cells by augmenting insulin receptor signaling and GLUT4 expression. Endocrinology. 152: 4581-8. PMID 21952243 DOI: 10.1210/En.2011-1268 |
0.338 |
|
| 2010 |
Durko M, Allen C, Nalbantoglu J, Karpati G. CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres. Journal of Muscle Research and Cell Motility. 31: 181-93. PMID 20706865 DOI: 10.1007/S10974-010-9222-9 |
0.369 |
|
| 2010 |
Feldman LA, Shapiro ML, Nalbantoglu J. A novel, rapidly acquired and persistent spatial memory task that induces immediate early gene expression. Behavioral and Brain Functions : Bbf. 6: 35. PMID 20594357 DOI: 10.1186/1744-9081-6-35 |
0.601 |
|
| 2010 |
Larochelle N, Teng Q, Gilbert R, Deol JR, Karpati G, Holland PC, Nalbantoglu J. Modulation of coxsackie and adenovirus receptor expression for gene transfer to normal and dystrophic skeletal muscle. The Journal of Gene Medicine. 12: 266-75. PMID 20082422 DOI: 10.1002/Jgm.1433 |
0.419 |
|
| 2009 |
Srivastava VK, Yasruel Z, Nalbantoglu J. Impaired medulloblastoma cell survival following activation of the FOXO1 transcription factor. International Journal of Oncology. 35: 1045-51. PMID 19787258 DOI: 10.3892/Ijo_00000419 |
0.316 |
|
| 2009 |
Lau CJ, Koty Z, Nalbantoglu J. Differential response of glioma cells to FOXO1-directed therapy. Cancer Research. 69: 5433-40. PMID 19549905 DOI: 10.1158/0008-5472.Can-08-4540 |
0.321 |
|
| 2008 |
Lu Y, Tian C, Danialou G, Gilbert R, Petrof BJ, Karpati G, Nalbantoglu J. Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function. The Journal of Biological Chemistry. 283: 34720-7. PMID 18945675 DOI: 10.1074/Jbc.M804518200 |
0.412 |
|
| 2008 |
Larochelle N, Deol JR, Srivastava V, Allen C, Mizuguchi H, Karpati G, Holland PC, Nalbantoglu J. Downregulation of CD46 during muscle differentiation: implications for gene transfer to human skeletal muscle using group B adenoviruses. Human Gene Therapy. 19: 133-42. PMID 18067405 DOI: 10.1089/Hum.2007.040 |
0.386 |
|
| 2007 |
Deol JR, Danialou G, Larochelle N, Bourget M, Moon JS, Liu AB, Gilbert R, Petrof BJ, Nalbantoglu J, Karpati G. Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1767-74. PMID 17667948 DOI: 10.1038/Sj.Mt.6300260 |
0.325 |
|
| 2006 |
Shaw CA, Larochelle N, Dudley RW, Lochmuller H, Danialou G, Petrof BJ, Karpati G, Holland PC, Nalbantoglu J. Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice. The American Journal of Pathology. 169: 2148-60. PMID 17148677 DOI: 10.2353/Ajpath.2006.060570 |
0.316 |
|
| 2006 |
Lau CJ, Bourbeau D, Jaime J, Nalbantoglu J, Massie B. 922. Improvement of Anti-Tumor Activity by Gene Amplification with a Replicative, Non-Disseminative Adenovirus Molecular Therapy. 13: S356-S357. DOI: 10.1016/J.Ymthe.2006.08.1013 |
0.372 |
|
| 2006 |
Deol JR, Gilbert R, Danialou G, Bourget M, Moon J, Petrof BJ, Nalbantoglu J, Karpati G. 919. Gene Therapy for Duchenne Muscular Dystrophy Using a Gutted Adenovirus Expressing Utrophin Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1009 |
0.401 |
|
| 2006 |
Larochelle N, Deol JR, Holland P, Karpati G, Nalbantoglu J. 913. Histone Deacetylase Inhibitors Improve Gene Transfer To Mature Skeletal Muscle Molecular Therapy. 13: S352. DOI: 10.1016/J.Ymthe.2006.08.1003 |
0.41 |
|
| 2006 |
Jaime J, Jabbour N, Parker W, Sorscher E, Nalbantoglu J, Massie B. 18. Comparison of Antitumor Activity of Cytosine Deaminase::Uracil Phosphoribosyl Transferase (CD::UPRT) and Purine Nucleoside Phosphorylase (PNP) Suicide Genes Using Replicative but Non-Disseminative Adenovirus Vectors Molecular Therapy. 13: S8. DOI: 10.1016/J.Ymthe.2006.08.029 |
0.375 |
|
| 2005 |
Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Cancer Research. 65: 8359-65. PMID 16166313 DOI: 10.1158/0008-5472.Can-05-0508 |
0.338 |
|
| 2005 |
Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G. Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle. Neuromuscular Disorders : Nmd. 15: 541-8. PMID 16014330 DOI: 10.1016/J.Nmd.2005.05.007 |
0.4 |
|
| 2005 |
Waheed I, Gilbert R, Nalbantoglu J, Guibinga GH, Petrof BJ, Karpati G. Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin. Human Gene Therapy. 16: 489-501. PMID 15871680 DOI: 10.1089/Hum.2005.16.489 |
0.397 |
|
| 2005 |
Danialou G, Comtois AS, Matecki S, Nalbantoglu J, Karpati G, Gilbert R, Geoffroy P, Gilligan S, Tanguay JF, Petrof BJ. Optimization of regional intraarterial naked DNA-mediated transgene delivery to skeletal muscles in a large animal model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 257-66. PMID 15668137 DOI: 10.1016/J.Ymthe.2004.09.016 |
0.392 |
|
| 2005 |
Huang KC, Altinoz M, Wosik K, Larochelle N, Koty Z, Zhu L, Holland PC, Nalbantoglu J. Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain. International Journal of Cancer. Journal International Du Cancer. 113: 738-45. PMID 15499626 DOI: 10.1002/Ijc.20623 |
0.341 |
|
| 2005 |
Deol JR, Gilbert R, Bourget M, Moon J, Nalbantoglu J, Karpati G. 256. An Ideal Therapeutic Agent for Duchenne Muscular Dystrophy Involving a Gutted Adenovirus Expressing Full-Length Utrophin Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.259 |
0.453 |
|
| 2004 |
Shaw CA, Holland PC, Sinnreich M, Allen C, Sollerbrant K, Karpati G, Nalbantoglu J. Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs. Bmc Cell Biology. 5: 42. PMID 15533241 DOI: 10.1186/1471-2121-5-42 |
0.377 |
|
| 2004 |
Bourbeau D, Lavoie G, Nalbantoglu J, Massie B. Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status. The Journal of Gene Medicine. 6: 1320-32. PMID 15515126 DOI: 10.1002/Jgm.611 |
0.337 |
|
| 2004 |
Molnar MJ, Gilbert R, Lu Y, Liu AB, Guo A, Larochelle N, Orlopp K, Lochmuller H, Petrof BJ, Nalbantoglu J, Karpati G. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 447-55. PMID 15336645 DOI: 10.1016/J.Ymthe.2004.06.642 |
0.431 |
|
| 2004 |
Matecki S, Dudley RW, Divangahi M, Gilbert R, Nalbantoglu J, Karpati G, Petrof BJ. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes. American Journal of Physiology. Lung Cellular and Molecular Physiology. 287: L569-76. PMID 15155269 DOI: 10.1152/Ajplung.00117.2004 |
0.448 |
|
| 2004 |
Dudley RW, Lu Y, Gilbert R, Matecki S, Nalbantoglu J, Petrof BJ, Karpati G. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector. Human Gene Therapy. 15: 145-56. PMID 14975187 DOI: 10.1089/104303404772679959 |
0.435 |
|
| 2004 |
Bourbeau D, Lau C, Lavoie G, Mes-Masson A, Nalbantoglu J, Massie B. 1032. Massive Expression of a Suicide Gene Using a Replicative but Non-Disseminative Adenovirus for Treatment of Solid Tumors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.977 |
0.375 |
|
| 2004 |
Perri SR, Nalbantoglu J, Annabi B, Koty Z, Béliveau R, Galipeau J. 972. Gene-Modified Human Glioma Cells Producing Soluble Human Plasminogen Kringle 5 Peptide Suppress Brain Tumor Progression Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.915 |
0.332 |
|
| 2003 |
Gilbert R, Dudley RW, Liu AB, Petrof BJ, Nalbantoglu J, Karpati G. Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Human Molecular Genetics. 12: 1287-99. PMID 12761044 DOI: 10.1093/Hmg/Ddg141 |
0.425 |
|
| 2002 |
Danialou G, Comtois AS, Dudley RW, Nalbantoglu J, Gilbert R, Karpati G, Jones DH, Petrof BJ. Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 687-93. PMID 12436962 DOI: 10.1006/Mthe.2002.0723 |
0.408 |
|
| 2002 |
Gilbert R, Liu A, Petrof B, Nalbantoglu J, Karpati G. Improved performance of a fully gutted adenovirus vector containing two full-length dystrophin cDNAs regulated by a strong promoter. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 501-9. PMID 12377192 DOI: 10.1006/Mthe.2002.0689 |
0.46 |
|
| 2002 |
Thirion C, Larochelle N, Volpers C, Dunant P, Stucka R, Holland P, Nalbantoglu J, Kochanek S, Lochmüller H. Strategies for muscle-specific targeting of adenoviral gene transfer vectors. Neuromuscular Disorders : Nmd. 12: S30-9. PMID 12206792 DOI: 10.1016/S0960-8966(02)00079-2 |
0.425 |
|
| 2002 |
Larochelle N, Oualikene W, Dunant P, Massie B, Karpati G, Nalbantoglu J, Lochmuller H. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice. Biochemical and Biophysical Research Communications. 292: 626-31. PMID 11922612 DOI: 10.1006/Bbrc.2002.6715 |
0.441 |
|
| 2001 |
Guibinga GH, Ebihara S, Nalbantoglu J, Holland P, Karpati G, Petrof BJ. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 499-507. PMID 11708887 DOI: 10.1006/Mthe.2001.0482 |
0.423 |
|
| 2001 |
Gilbert R, Nalbantoglu J, Howell JM, Davies L, Fletcher S, Amalfitano A, Petrof BJ, Kamen A, Massie B, Karpati G. Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products. Human Gene Therapy. 12: 1741-55. PMID 11560768 DOI: 10.1089/104303401750476249 |
0.446 |
|
| 2001 |
Nalbantoglu J, Larochelle N, Wolf E, Karpati G, Lochmuller H, Holland PC. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle. Journal of Virology. 75: 4276-82. PMID 11287577 DOI: 10.1128/Jvi.75.9.4276-4282.2001 |
0.446 |
|
| 2001 |
Wosik K, Becher B, Ezman A, Nalbantoglu J, Antel JP. Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes Glia. 33: 217-224. PMID 11241739 DOI: 10.1002/1098-1136(200103)33:3<217::Aid-Glia1020>3.0.Co;2-W |
0.32 |
|
| 2000 |
Ebihara S, Guibinga GH, Gilbert R, Nalbantoglu J, Massie B, Karpati G, Petrof BJ. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiological Genomics. 3: 133-44. PMID 11015608 DOI: 10.1152/Physiolgenomics.2000.3.3.133 |
0.441 |
|
| 2000 |
Adesina AM, Dunn ST, Moore WE, Nalbantoglu J. Expression of p27kip1 and p53 in medulloblastoma: relationship with cell proliferation and survival. Pathology, Research and Practice. 196: 243-50. PMID 10782468 DOI: 10.1016/S0344-0338(00)80073-4 |
0.333 |
|
| 2000 |
Cho WK, Ebihara S, Nalbantoglu J, Gilbert R, Massie B, Holland P, Karpati G, Petrof BJ. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Human Gene Therapy. 11: 701-14. PMID 10757350 DOI: 10.1089/10430340050015608 |
0.436 |
|
| 1999 |
Pari G, Crerar MM, Nalbantoglu J, Shoubridge E, Jani A, Tsujino S, Shanske S, DiMauro S, Howell JM, Karpati G. Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro Neurology. 53: 1352-1354. PMID 10522901 DOI: 10.1212/Wnl.53.6.1352 |
0.367 |
|
| 1999 |
Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, Kamen A, Massie B, Davies KE, Karpati G. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Human Gene Therapy. 10: 1299-310. PMID 10365661 DOI: 10.1089/10430349950017987 |
0.439 |
|
| 1999 |
Nalbantoglu J, Pari G, Karpati G, Holland PC. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Human Gene Therapy. 10: 1009-19. PMID 10223734 DOI: 10.1089/10430349950018409 |
0.433 |
|
| 1998 |
Acsadi G, O'Hagan D, Lochmüller H, Prescott S, Larochelle N, Nalbantoglu J, Jani A, Karpati G. Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells Journal of Molecular Medicine. 76: 442-450. PMID 9625301 DOI: 10.1007/s001090050236 |
0.363 |
|
| 1998 |
Yang L, Lochmuller H, Luo J, Massie B, Nalbantoglu J, Karpati G, Petrof BJ. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Therapy. 5: 369-79. PMID 9614557 DOI: 10.1038/Sj.Gt.3300600 |
0.431 |
|
| 1998 |
Guibinga GH, Lochmuller H, Massie B, Nalbantoglu J, Karpati G, Petrof BJ. Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. Journal of Virology. 72: 4601-9. PMID 9573223 DOI: 10.1128/Jvi.72.6.4601-4609.1998 |
0.392 |
|
| 1998 |
Howell JM, Lochmüller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Human Gene Therapy. 9: 629-34. PMID 9551611 DOI: 10.1089/Hum.1998.9.5-629 |
0.448 |
|
| 1997 |
Karpati G, Gilbert R, Petrof BJ, Nalbantoglu J. Gene therapy research for Duchenne and Becker muscular dystrophies. Current Opinion in Neurology. 10: 430-5. PMID 9330891 DOI: 10.1097/00019052-199710000-00013 |
0.405 |
|
| 1997 |
Zhao JE, Lochumüller H, Nalbantoglu J, Allen C, Prescott S, Massie B, Karpati G. Study of adenovirus-mediated dystrophin minigene transfer to skeletal muscle by combined microscopic display of adenoviral DNA and dystrophin. Human Gene Therapy. 8: 1565-73. PMID 9322089 DOI: 10.1089/Hum.1997.8.13-1565 |
0.368 |
|
| 1997 |
Larochelle N, Lochmüller H, Zhao J, Jani A, Hallauer P, Hastings KE, Massie B, Prescott S, Petrof BJ, Karpati G, Nalbantoglu J. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer. Gene Therapy. 4: 465-72. PMID 9274724 DOI: 10.1038/Sj.Gt.3300414 |
0.444 |
|
| 1997 |
Li H, Lochmüller H, Yong VW, Karpati G, Nalbantoglu J. Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status Journal of Neuropathology and Experimental Neurology. 56: 872-878. PMID 9258257 DOI: 10.1097/00005072-199708000-00005 |
0.319 |
|
| 1997 |
Durham HD, Alonso-Vanegas MA, Sadikot AF, Zhu L, Lochmüller H, Massie B, Nalbantoglu J, Karpati G. The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transfer Neuroreport. 8: 2111-2115. PMID 9243594 DOI: 10.1097/00001756-199707070-00005 |
0.379 |
|
| 1997 |
Shekarabi M, Bourbonnière M, Dagenais A, Nalbantoglu J. Transcriptional regulation of amyloid precursor protein during dibutyryl cyclic AMP-induced differentiation of NG108-15 cells Journal of Neurochemistry. 68: 970-978. PMID 9048742 DOI: 10.1046/J.1471-4159.1997.68030970.X |
0.358 |
|
| 1997 |
Bourbonnière M, Shekarabi M, Nalbantoglu J. Enhanced expression of amyloid precursor protein in response to dibutyryl cyclic AMP is not mediated by the transcription factor AP-2 Journal of Neurochemistry. 68: 909-916. PMID 9048735 DOI: 10.1046/J.1471-4159.1997.68030909.X |
0.339 |
|
| 1996 |
Petrof BJ, Lochmüller H, Massie B, Yang L, Macmillan C, Zhao JE, Nalbantoglu J, Karpati G. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency. Human Gene Therapy. 7: 1813-26. PMID 8894673 DOI: 10.1089/Hum.1996.7.15-1813 |
0.429 |
|
| 1996 |
Lochmüller H, Petrof BJ, Pari G, Larochelle N, Dodelet V, Wang Q, Allen C, Prescott S, Massie B, Nalbantoglu J, Karpati G. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Therapy. 3: 706-16. PMID 8854096 |
0.346 |
|
| 1996 |
Karpati G, Lochmüller H, Nalbantoglu J, Durham H. The principles of gene therapy for the nervous system Trends in Neurosciences. 19: 49-54. PMID 8820867 DOI: 10.1016/0166-2236(96)89620-2 |
0.369 |
|
| 1996 |
Bourbonnière M, Nalbantoglu J. The helix-loop-helix transcription factor USF interacts with the basal promoter of human amyloid precursor protein Molecular Brain Research. 35: 304-308. PMID 8717367 DOI: 10.1016/0169-328X(95)00208-A |
0.335 |
|
| 1995 |
McLaurin J, D'Souza S, Stewart J, Blain M, Beaudet A, Nalbantoglu J, Antel JP. Effect of tumor necrosis factor α and β on human oligodendrocytes and neurons in culture International Journal of Developmental Neuroscience. 13: 369-381. PMID 7572288 DOI: 10.1016/0736-5748(95)00012-6 |
0.303 |
|
| 1995 |
Durham HD, O'Brien C, Nalbantoglu J, Figlewicz DA. Use of tissue culture models to study environmental-genetic interactions relevant to neurodegenerative diseases. Clinical and Experimental Pharmacology & Physiology. 22: 366-7. PMID 7554432 DOI: 10.1111/J.1440-1681.1995.Tb02019.X |
0.341 |
|
| 1995 |
Ledoux S, Bergeron C, Nalbantoglu J, Gauthier S, Cashman NR. Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome Neuroscience Letters. 193: 137-139. PMID 7478160 DOI: 10.1016/0304-3940(95)11681-L |
0.313 |
|
| 1994 |
Durham HD, Minotti S, Dooley NP, Nalbantoglu J. Expression of the intermediate filament-associated protein related to β- amyloid precursor protein is developmentally regulated in cultured cells Journal of Neuroscience Research. 38: 629-639. PMID 7807580 DOI: 10.1002/Jnr.490380605 |
0.336 |
|
| 1994 |
Ledoux S, Nalbantoglu J, Cashman NR. Amyloid precursor protein gene expression in neural cell lines: influence of DNA cytosine methylation Molecular Brain Research. 24: 140-144. PMID 7526112 DOI: 10.1016/0169-328X(94)90125-2 |
0.357 |
|
| 1990 |
Lacoste-Royal G, Mathieu M, Nalbantoglu J, Julien JP, Gauthier S, Gauvreau D. Lack of association between two restriction fragment length polymorphisms in the genes for the light and heavy neurofilament proteins and Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 17: 302-5. PMID 1976427 DOI: 10.1017/S0317167100030614 |
0.305 |
|
| Show low-probability matches. |